Elevating Healthcare Analytics
Experts in Clinical Decision Support
At CereHealth, our mission is to revolutionize healthcare through the power of artificial intelligence. We are committed to improving patient outcomes and enhancing the efficiency of clinical practices by providing cutting-edge AI-driven and explainable Clinical Decision Support Systems (CDSS).
Our purpose is to bridge the gap between data and insights, enabling healthcare professionals to make more informed and precise decisions at every critical juncture. By harnessing the potential of AI, we aim to empower medical experts with real-time, evidence-based recommendations that promote accurate diagnoses, personalized treatment plans, and optimize patient care.
Driven by our dedication to innovation and integrity, we envision a future where healthcare providers can seamlessly integrate AI into their workflows. Through continuous research, collaboration, and advancements in AI technology, we strive to be at the forefront of CDSS, setting new standards for excellence in healthcare decision-making.
We are unwavering in our commitment to privacy and security, ensuring that patient data is treated with the utmost privacy and security, and adhering to the highest standards of compliance. Our solutions are designed not only to support medical professionals but also to engender trust among patients, knowing that their well-being remains at the heart of every AI-driven recommendation.
We are dedicated to shaping a healthier tomorrow through the synergy of AI and medical wisdom.
Chairman & Executive Director
President & CTO
Dr. Shaun O’Leary, MD, PhD, MHCM
Chief Medical Advisor
Brett Green, Esq.
VP Legal & Quality
VP Sales & Business Development
In the News
CereHealth Promotes Shane Quint to President and Hires Wendy Turman as Chief Financial Officer to Support Launch iLLUME Ai Software Platform
Littleton, Colorado, September 21, 2022 – CereHealth Corporation, a healthcare technology company that provides a browser based clinical decision support and predictive analytics platform called
CereMetrix 2.0 leverages the platform’s quantitative SPECT imaging and reporting capabilities to accommodate a broader range of modality agnostic clinical and research applications. Read Press
CereHealth Corporation has been granted a 3rd patent on its novel medical imaging and data analytics technology. Read Press Release
The iLLUME Ai platform breaks through the barriers preventing everyday medical data from serving the very people generating it.
View Open Positions
We are looking for qualified candidates who share our passion to innovate patient care through data.